Keyphrases
Pericyte-like Cells
48%
In Vitro Cell Models
48%
Myeloid Angiogenic Cells
48%
Epithelial Erosions
48%
Tissue Integrity
48%
Intestinal Epithelial Cells
48%
Desmosome
48%
Inflammatory Macrophages
48%
Macrophage Populations
48%
Targeted Deletion
48%
Zoledronate
48%
Prognostic Value
48%
3-year Follow-up
48%
Anatomical Parts
48%
Structural Abnormalities
48%
White Adipose Tissue Inflammation
48%
Chemokine (C-C motif) Ligand 2 (CCL2)
48%
Anti-inflammatory Signaling
48%
Maternal Hyperglycemia
48%
Reporter Gene
48%
Aromatase Expression
48%
Weight Gain
48%
Adipose Tissue
48%
Gene Activity
48%
Guardian
48%
PC-3M
48%
Serum Interleukins
48%
Stilbenoids
48%
Selective Estrogen Receptor Modulators
48%
Anti-inflammatory Phenotype
48%
Keratin Intermediate Filaments
48%
CD14+ Cells
48%
Luc2
48%
Anticarcinogenic
48%
Prostate Cancer Model
48%
Proteome Coverage
48%
Breast Milk
48%
Milk Proteome
48%
Probiotic Intervention
48%
Immune Mediators
48%
Double-blind Clinical Trial
48%
Randomized Placebo-controlled Trial
48%
Colostrum
48%
Female Mice
48%
Receptor Antagonism
48%
Estrogen Deprivation
48%
DSS-induced Colitis
48%
Genetic Deficiency
48%
Mesenchymal Stromal Cells
42%
White Adipose Tissue
36%
Medicine and Dentistry
Inflammatory Bowel Disease
100%
Gene Expression
63%
Colon
58%
Neoplasm
51%
Keratin 7
51%
Macrophage
48%
Keratin
48%
Positron Emission Tomography
48%
Liposome
48%
Triple Negative Breast Cancer
48%
Gallium 68
48%
Sialic Acid Binding Immunoglobulin Like Lectin
48%
Enteritis
48%
Hyperglycemia
48%
Desmosome
48%
Intermediate Filament
48%
Homeostasis
48%
Tetraxetan
48%
Vascular Adhesion Protein-1
48%
Aromatase
48%
Hemodynamic
48%
Drug Resistance
48%
Zoledronic Acid
48%
Colostrum
48%
Placebo
48%
Umbilical Artery
24%
Pulsatility Index
15%
Ductus Venosus
15%
Platelet Derived Growth Factor Beta Receptor
15%
Descending Aorta
15%
Polypeptide
15%
Immunofluorescence
14%
Breast Cancer
13%
Ex Vivo
12%
Dextran Sulfate
12%
Intestine
12%
Proteus Syndrome
12%
Osteophyte
12%
Eosinophilic Esophagitis
12%
Cytokine
10%
Biological Marker
10%
Diseases
9%
Metastatic Carcinoma
9%
Intermediate Filament Protein
9%
Tumor Progression
8%
Epithelial Cell
8%
Diagnosis
8%
Pregnancy
8%
Type II Keratin
8%
Fetus Control
8%